Lazaro Cordoves, MD
Psychiatry · Hialeah, FLNPI 1821126079
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,607 of the $2,196 with a category attached, or 73.2%. Janssen Research & Development, LLC accounts for 89.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $2,139, more than ten times the $40 reported in 2022.
Across 20 payments — averaging $109.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$2K
- Teva Pharmaceuticals USA, Inc.$180
- Biomarin Pharmaceutical Inc.$25
- Otsuka America Pharmaceutical, Inc.$17
Across 28 payments — averaging $14,495 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$339K
- Janssen Research & Development, LLC$50K
- Biohaven Pharmaceuticals, Inc.$16K
What the payments were for
- Travel & lodging$1,60773%
- Food & beverage$58927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 13 | $1,974 |
| Teva Pharmaceuticals USA, Inc. | 5 | $180 |
| Biomarin Pharmaceutical Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$122
How this compares
$2,196 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 121 | $677,770 |
| Clonazepam | 1,106 | $15,257 |
| Mirtazapine | 362 | $10,996 |
| Lorazepam | 192 | $2,934 |
| Temazepam | 191 | $2,785 |
| Clozapine | 25 | $2,721 |
| Risperidone | 99 | $1,884 |
| Quetiapine Fumarate | 77 | $1,579 |
| Haloperidol | 17 | $1,322 |
| Olanzapine | 43 | $1,286 |
| Doxepin Hcl | 19 | $1,181 |
| Escitalopram Oxalate | 65 | $878 |
| Duloxetine Hcl | 60 | $866 |
| Memantine Hcl | 26 | $865 |
| Alprazolam | 47 | $661 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Hialeah
- Jose GamezHialeah$557K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.